167 related articles for article (PubMed ID: 14696970)
1. P2 receptors in bone--modulation of osteoclast formation and activity via P2X7 activation.
Gartland A; Buckley KA; Hipskind RA; Bowler WB; Gallagher JA
Crit Rev Eukaryot Gene Expr; 2003; 13(2-4):237-42. PubMed ID: 14696970
[TBL] [Abstract][Full Text] [Related]
2. ATP P2 receptors and regulation of bone effector cells.
Gallagher JA
J Musculoskelet Neuronal Interact; 2004 Jun; 4(2):125-7. PubMed ID: 15615109
[TBL] [Abstract][Full Text] [Related]
3. ATP and UTP at low concentrations strongly inhibit bone formation by osteoblasts: a novel role for the P2Y2 receptor in bone remodeling.
Hoebertz A; Mahendran S; Burnstock G; Arnett TR
J Cell Biochem; 2002; 86(3):413-9. PubMed ID: 12210747
[TBL] [Abstract][Full Text] [Related]
4. Blockade of the pore-forming P2X7 receptor inhibits formation of multinucleated human osteoclasts in vitro.
Gartland A; Buckley KA; Bowler WB; Gallagher JA
Calcif Tissue Int; 2003 Oct; 73(4):361-9. PubMed ID: 12874700
[TBL] [Abstract][Full Text] [Related]
5. [P2 purinergic receptors: regulation of bone metabolism and therapeutic potential?].
Solgaard M; Jørgensen NR
Ugeskr Laeger; 2005 Aug; 167(34):3152-6. PubMed ID: 16117911
[TBL] [Abstract][Full Text] [Related]
6. Expression and function of P2 receptors in bone.
Gallagher JA; Buckley KA
J Musculoskelet Neuronal Interact; 2002 Sep; 2(5):432-9. PubMed ID: 15758411
[TBL] [Abstract][Full Text] [Related]
7. Boning up on ephrin signaling.
Mundy GR; Elefteriou F
Cell; 2006 Aug; 126(3):441-3. PubMed ID: 16901775
[TBL] [Abstract][Full Text] [Related]
8. Release and interconversion of P2 receptor agonists by human osteoblast-like cells.
Buckley KA; Golding SL; Rice JM; Dillon JP; Gallagher JA
FASEB J; 2003 Aug; 17(11):1401-10. PubMed ID: 12890693
[TBL] [Abstract][Full Text] [Related]
9. Expression of a P2X7 receptor by a subpopulation of human osteoblasts.
Gartland A; Hipskind RA; Gallagher JA; Bowler WB
J Bone Miner Res; 2001 May; 16(5):846-56. PubMed ID: 11341329
[TBL] [Abstract][Full Text] [Related]
10. Osteoblast responses to nucleotides increase during differentiation.
Orriss IR; Knight GE; Ranasinghe S; Burnstock G; Arnett TR
Bone; 2006 Aug; 39(2):300-9. PubMed ID: 16616882
[TBL] [Abstract][Full Text] [Related]
11. Role of purinergic receptor polymorphisms in human bone.
Wesselius A; Bours MJ; Agrawal A; Gartland A; Dagnelie PC; Schwarz P; Jorgensen NR
Front Biosci (Landmark Ed); 2011 Jun; 16(7):2572-85. PubMed ID: 21622196
[TBL] [Abstract][Full Text] [Related]
12. Single nucleotide polymorphisms in the P2X7 gene are associated to fracture risk and to effect of estrogen treatment.
Ohlendorff SD; Tofteng CL; Jensen JE; Petersen S; Civitelli R; Fenger M; Abrahamsen B; Hermann AP; Eiken P; Jørgensen NR
Pharmacogenet Genomics; 2007 Jul; 17(7):555-67. PubMed ID: 17558311
[TBL] [Abstract][Full Text] [Related]
13. Involvement of P2 receptors in the growth and survival of neurons in the CNS.
Franke H; Illes P
Pharmacol Ther; 2006 Mar; 109(3):297-324. PubMed ID: 16102837
[TBL] [Abstract][Full Text] [Related]
14. Nucleotide receptors stimulation by extracellular ATP controls Hsp90 expression through APE1/Ref-1 in thyroid cancer cells: a novel tumorigenic pathway.
Pines A; Bivi N; Vascotto C; Romanello M; D'Ambrosio C; Scaloni A; Damante G; Morisi R; Filetti S; Ferretti E; Quadrifoglio F; Tell G
J Cell Physiol; 2006 Oct; 209(1):44-55. PubMed ID: 16741950
[TBL] [Abstract][Full Text] [Related]
15. Purinergic signalling and bone remodelling.
Orriss IR; Burnstock G; Arnett TR
Curr Opin Pharmacol; 2010 Jun; 10(3):322-30. PubMed ID: 20189453
[TBL] [Abstract][Full Text] [Related]
16. A putative osmoreceptor system that controls neutrophil function through the release of ATP, its conversion to adenosine, and activation of A2 adenosine and P2 receptors.
Chen Y; Shukla A; Namiki S; Insel PA; Junger WG
J Leukoc Biol; 2004 Jul; 76(1):245-53. PubMed ID: 15107462
[TBL] [Abstract][Full Text] [Related]
17. Intercellular calcium signaling occurs between human osteoblasts and osteoclasts and requires activation of osteoclast P2X7 receptors.
Jørgensen NR; Henriksen Z; Sørensen OH; Eriksen EF; Civitelli R; Steinberg TH
J Biol Chem; 2002 Mar; 277(9):7574-80. PubMed ID: 11756404
[TBL] [Abstract][Full Text] [Related]
18. Novel insights into how purines regulate pituitary cell function.
Rees DA; Scanlon MF; Ham J
Clin Sci (Lond); 2003 May; 104(5):467-81. PubMed ID: 12578557
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor beta derived from bone matrix promotes cell proliferation of prostate cancer and osteoclast activation-associated osteolysis in the bone microenvironment.
Sato S; Futakuchi M; Ogawa K; Asamoto M; Nakao K; Asai K; Shirai T
Cancer Sci; 2008 Feb; 99(2):316-23. PubMed ID: 18271931
[TBL] [Abstract][Full Text] [Related]
20. Activation of P2X7 receptors causes isoform-specific translocation of protein kinase C in osteoclasts.
Armstrong S; Pereverzev A; Dixon SJ; Sims SM
J Cell Sci; 2009 Jan; 122(Pt 1):136-44. PubMed ID: 19066285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
